RNS Number:8107S
Maelor PLC
22 April 2008

22 April 2008



                    Maelor plc ( 'Maelor' or the 'Company')



                           Consolidation and Placing



The Board of Maelor plc (AIM:MLR), the specialist hospital medicines group, is
pleased to announce that it has conditionally raised �10.0 million through an
over subscribed placing of 13,000,000 consolidated ordinary shares of 70 pence
nominal value (the 'Placing') by Noble & Company Limited, Maelor's nominated
adviser and broker.



Following the consolidation of the Company's existing ordinary shares on a 1 for
7 basis, commencement of dealings in relation to the 17,754,404 existing
consolidated ordinary shares of 70 pence nominal value will take place today, on
Tuesday 22 April 2008, at 8:00am. The ISIN of the consolidated ordinary shares
is GB00B2QBY649.



First Admission and the commencement of dealings in relation to the 2,288,918
First EIS/VCT Shares will also take place today, on Tuesday 22 April, at 8:00am.
It is expected that Second Admission and the commencement of dealings in
relation to the 546,600 Second VCT Shares will occur at 8am on 23 April 2008;
that Third Admission and commencement of dealings in relation to the 8,286,482
Third VCT Shares will occur at 8am on 24 April 2007; and that Fourth Admission
and the commencement of dealings in relation to the 1,878,000 Non-EIS/VCT Shares
will occur at 8am on 25 April 2007. Following completion of the Fourth Admission
the Company will have 30,754,404 ordinary shares of 70 pence nominal value in
issue.



Geoff McMillan, Non-Executive Chairman, Tim Wright, Chief Executive Officer,
Nigel Goldsmith, Finance Director, Ann Hardy, Executive Director, John Gregory,
Non-Executive Director and Peter Murray, Non-Executive Director have all
participated in the Placing.



The Board anticipates notifying the market of the completion of the acquisition
of Speciality European Pharma International AG on 28 April 2008.



Tim Wright, CEO of Maelor said:

"We are very pleased to have completed this significant fundraising, which was
over subscribed and took place in turbulent markets. We believe it shows the
strength of belief in the opportunity that Maelor presents and the strategy to
which the business has been delivering ever since the strengthened management
team was put in place."





                                    - ENDS -


Enquiries:

Maelor plc                                              Tel: +44(0) 1244 625150
Tim Wright - CEO
www.maelor.plc.uk

Financial Dynamics Limited                              Tel: +44(0) 20 7831 3113
Billy Clegg / Edward Westropp

Noble & Company Limited                                 Tel: +44(0) 20 7763 2200
Matthew Hall / Sam Reynolds



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCVFLFLVZBLBBQ

Maelor (LSE:MLR)
過去 株価チャート
から 5 2024 まで 6 2024 Maelorのチャートをもっと見るにはこちらをクリック
Maelor (LSE:MLR)
過去 株価チャート
から 6 2023 まで 6 2024 Maelorのチャートをもっと見るにはこちらをクリック